This report assesses the impact of fiscal and monetary policy on the activities of various organisations in the pharmaceutical industry. It also analyzes how corporate social responsibility, ethics, global and regional factors have shaped the activities of these organisations. The report focuses on Actavis in the US and Canada drugs direct in Canada, and discusses the impact of fiscal and monetary policy on these pharmaceutical companies.